Published in Infect Immun on July 01, 2005
This is not your mother's repressor: the complex role of fur in pathogenesis. Infect Immun (2009) 1.71
TonB-Dependent Transporters Expressed by Neisseria gonorrhoeae. Front Microbiol (2011) 1.01
Fur-mediated activation of gene transcription in the human pathogen Neisseria gonorrhoeae. J Bacteriol (2012) 0.93
The Gonococcal Transcriptome during Infection of the Lower Genital Tract in Women. PLoS One (2015) 0.91
Expression of the gonococcal global regulatory protein Fur and genes encompassing the Fur and iron regulon during in vitro and in vivo infection in women. J Bacteriol (2008) 0.90
Identification and characterization of gonococcal iron transport systems as potential vaccine antigens. Future Microbiol (2008) 0.85
Type I Interferon Induction by Neisseria gonorrhoeae: Dual Requirement of Cyclic GMP-AMP Synthase and Toll-like Receptor 4. Cell Rep (2016) 0.83
Fur-mediated global regulatory circuits in pathogenic Neisseria species. J Bacteriol (2012) 0.83
A high-throughput method to examine protein-nucleotide interactions identifies targets of the bacterial transcriptional regulatory protein fur. PLoS One (2014) 0.79
Characterization of the Neisseria gonorrhoeae Iron and Fur Regulatory Network. J Bacteriol (2016) 0.77
Neisseria gonorrhoeae Crippled Its Peptidoglycan Fragment Permease To Facilitate Toxic Peptidoglycan Monomer Release. J Bacteriol (2016) 0.75
A small RNA regulates the expression of genes involved in iron metabolism in Escherichia coli. Proc Natl Acad Sci U S A (2002) 7.99
Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet (1997) 6.34
Ability of Neisseria gonorrhoeae, Neisseria meningitidis, and commensal Neisseria species to obtain iron from transferrin and iron compounds. Infect Immun (1981) 4.28
Ability of Neisseria gonorrhoeae, Neisseria meningitidis, and commensal Neisseria species to obtain iron from lactoferrin. Infect Immun (1982) 3.27
Iron acquisition by Neisseria meningitidis in vitro. Infect Immun (1980) 3.06
Purification and partial characterization of the major outer membrane protein of Neisseria gonorrhoeae. Infect Immun (1982) 2.70
Fur positive regulation of iron superoxide dismutase in Escherichia coli: functional analysis of the sodB promoter. J Bacteriol (2000) 2.60
Bacterial solutions to the iron-supply problem. Trends Biochem Sci (1999) 2.53
Immunoglobulin G antibodies directed against protein III block killing of serum-resistant Neisseria gonorrhoeae by immune serum. J Exp Med (1986) 2.40
The transferrin receptor expressed by gonococcal strain FA1090 is required for the experimental infection of human male volunteers. Mol Microbiol (1998) 2.33
Gonococcal transferrin-binding protein 2 facilitates but is not essential for transferrin utilization. J Bacteriol (1994) 2.32
Identification of iron-activated and -repressed Fur-dependent genes by transcriptome analysis of Neisseria meningitidis group B. Proc Natl Acad Sci U S A (2003) 2.17
Purine metabolism in Neisseria gonorrhoeae: the requirement for hypoxanthine. Can J Microbiol (1980) 2.08
Fur functions as an activator and as a repressor of putative virulence genes in Neisseria meningitidis. Mol Microbiol (2004) 2.08
Iron acquisition in microbial pathogenesis. Trends Microbiol (1993) 1.99
The Fur repressor controls transcription of iron-activated and -repressed genes in Helicobacter pylori. Mol Microbiol (2001) 1.96
Evaluation of transferrin-binding protein 2 within the transferrin-binding protein complex as a potential antigen for future meningococcal vaccines. Infect Immun (1995) 1.60
The ferric iron-binding protein of pathogenic Neisseria spp. functions as a periplasmic transport protein in iron acquisition from human transferrin. Mol Microbiol (1993) 1.54
Immune responses in humans and animals to meningococcal transferrin-binding proteins: implications for vaccine design. Infect Immun (1994) 1.51
Fur-mediated transcriptional and post-transcriptional regulation of FeSOD expression in Escherichia coli. Microbiology (2002) 1.46
Antibody-antigen specificity in the immune response to infection with Neisseria gonorrhoeae. J Infect Dis (1985) 1.39
Characterization of the diversity and the transferrin-binding domain of gonococcal transferrin-binding protein 2. Infect Immun (1997) 1.34
The gonococcal fur regulon: identification of additional genes involved in major catabolic, recombination, and secretory pathways. J Bacteriol (2002) 1.26
Gonococcal porin vaccine evaluation: comparison of Por proteosomes, liposomes, and blebs isolated from rmp deletion mutants. J Infect Dis (1992) 1.25
Expression of the Haemophilus influenzae transferrin receptor is repressible by hemin but not elemental iron alone. Infect Immun (1993) 1.23
Human antibody response to meningococcal transferrin binding proteins: evidence for vaccine potential. Vaccine (1995) 1.21
Energy-dependent changes in the gonococcal transferrin receptor. Mol Microbiol (1997) 1.20
Complement processing and immunoglobulin binding to Neisseria gonorrhoeae determined in vitro simulates in vivo effects. J Infect Dis (1999) 1.09
Biochemical analysis of lactoferrin receptors in the Neisseriaceae: identification of a second bacterial lactoferrin receptor protein. Microb Pathog (1995) 1.09
Antigenic and sequence diversity in gonococcal transferrin-binding protein A. Infect Immun (2000) 1.09
Antibody to Rmp (outer membrane protein 3) increases susceptibility to gonococcal infection. J Clin Invest (1993) 1.08
Antibodies to opacity proteins (Opa) correlate with a reduced risk of gonococcal salpingitis. J Clin Invest (1994) 1.05
Identification of sequences in human transferrin that bind to the bacterial receptor protein, transferrin-binding protein B. Mol Microbiol (1999) 1.05
The development of awareness of iron-withholding defense. Perspect Biol Med (1993) 1.05
Antibodies to Neisseria gonorrhoeae: a study of the urethral exudates of 232 men. J Infect Dis (1979) 1.05
Analysis of antibodies in local and disseminated Neisseria gonorrhoeae infections by means of gel electrophoresis-derived ELISA. Immunology (1982) 0.98
T lymphocyte response to Neisseria gonorrhoeae porin in individuals with mucosal gonococcal infections. J Infect Dis (1999) 0.97
Immunogenicity of gonococcal transferrin binding proteins during natural infections. Infect Immun (2004) 0.93
In vivo human immune response to transferrin-binding protein 2 and other iron-regulated proteins of Neisseria meningitidis. FEMS Immunol Med Microbiol (1994) 0.92
Analysis of the human Ig isotype response to individual transferrin binding proteins A and B from Neisseria meningitidis. FEMS Immunol Med Microbiol (1997) 0.88
Humoral immune response to gonococcal infections. Clin Microbiol Rev (1989) 0.86
International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis (2011) 12.29
Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial. Am J Obstet Gynecol (2002) 4.18
Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab (2007) 3.36
Computational analysis of bacterial RNA-Seq data. Nucleic Acids Res (2013) 2.50
Abortion and clostridial toxic shock syndrome. Obstet Gynecol (2007) 2.49
Vaginal swabs are appropriate specimens for diagnosis of genital tract infection with Chlamydia trachomatis. J Clin Microbiol (2003) 2.24
Cutting edge: Immune stimulation by neisserial porins is toll-like receptor 2 and MyD88 dependent. J Immunol (2002) 2.00
Fortification of orange juice with vitamin D(2) or vitamin D(3) is as effective as an oral supplement in maintaining vitamin D status in adults. Am J Clin Nutr (2010) 1.97
A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease. Am J Epidemiol (2005) 1.94
Bacterial vaginosis (BV) and the risk of incident gonococcal or chlamydial genital infection in a predominantly black population. Sex Transm Dis (2005) 1.82
Douching in relation to bacterial vaginosis, lactobacilli, and facultative bacteria in the vagina. Obstet Gynecol (2002) 1.73
Infections of people with complement deficiencies and patients who have undergone splenectomy. Clin Microbiol Rev (2010) 1.70
A meningococcal factor H binding protein mutant that eliminates factor H binding enhances protective antibody responses to vaccination. J Immunol (2011) 1.68
Toll-like receptor 2 plays a critical role in the progression of atherosclerosis that is independent of dietary lipids. Atherosclerosis (2007) 1.67
Effectiveness of two tinidazole regimens in treatment of bacterial vaginosis: a randomized controlled trial. Obstet Gynecol (2007) 1.63
Effectiveness of treatment strategies of some women with pelvic inflammatory disease: a randomized trial. Obstet Gynecol (2005) 1.60
Neisserial lipooligosaccharide is a target for complement component C4b. Inner core phosphoethanolamine residues define C4b linkage specificity. J Biol Chem (2003) 1.55
Stimulation of Toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase. Circ Res (2008) 1.52
Pneumonia in pregnancy. Crit Care Med (2005) 1.48
Do short-term markers of treatment efficacy predict long-term sequelae of pelvic inflammatory disease? Am J Obstet Gynecol (2008) 1.45
Hemin-dependent modulation of the lipid A structure of Porphyromonas gingivalis lipopolysaccharide. Infect Immun (2006) 1.45
Meningococcal porin PorB binds to TLR2 and requires TLR1 for signaling. J Immunol (2006) 1.44
Bacteriuria in pregnant women with sickle cell trait. Am J Obstet Gynecol (2006) 1.43
Distinct defensin profiles in Neisseria gonorrhoeae and Chlamydia trachomatis urethritis reveal novel epithelial cell-neutrophil interactions. Infect Immun (2005) 1.41
Human factor H interacts selectively with Neisseria gonorrhoeae and results in species-specific complement evasion. J Immunol (2008) 1.39
A novel fur- and iron-regulated small RNA, NrrF, is required for indirect fur-mediated regulation of the sdhA and sdhC genes in Neisseria meningitidis. J Bacteriol (2007) 1.37
Engagement of specific innate immune signaling pathways during Porphyromonas gingivalis induced chronic inflammation and atherosclerosis. Front Biosci (2008) 1.37
Phosphoethanolamine substitution of lipid A and resistance of Neisseria gonorrhoeae to cationic antimicrobial peptides and complement-mediated killing by normal human serum. Infect Immun (2008) 1.32
Can known risk factors explain racial differences in the occurrence of bacterial vaginosis? J Natl Med Assoc (2003) 1.30
The role of porins in neisserial pathogenesis and immunity. Trends Microbiol (2003) 1.30
The Role of TLR2 in Infection and Immunity. Front Immunol (2012) 1.28
T cell activation by TLRs: a role for TLRs in the adaptive immune response. Sci STKE (2007) 1.28
Why women douche and why they may or may not stop. Sex Transm Dis (2003) 1.26
Neisserial PorB is translocated to the mitochondria of HeLa cells infected with Neisseria meningitidis and protects cells from apoptosis. Cell Microbiol (2003) 1.23
Implications of phase variation of a gene (pgtA) encoding a pilin galactosyl transferase in gonococcal pathogenesis. J Exp Med (2002) 1.22
Pathogen-mediated inflammatory atherosclerosis is mediated in part via Toll-like receptor 2-induced inflammatory responses. J Innate Immun (2010) 1.21
Neisserial porin-induced dendritic cell activation is MyD88 and TLR2 dependent. J Immunol (2005) 1.20
Human C4b-binding protein selectively interacts with Neisseria gonorrhoeae and results in species-specific infection. Proc Natl Acad Sci U S A (2005) 1.20
Factor H binding and function in sialylated pathogenic neisseriae is influenced by gonococcal, but not meningococcal, porin. J Immunol (2007) 1.20
Bacterial vaginosis and risk of pelvic inflammatory disease. Obstet Gynecol (2004) 1.20
Bacterial fimbriae stimulate proinflammatory activation in the endothelium through distinct TLRs. J Immunol (2008) 1.19
Macrophage-specific TLR2 signaling mediates pathogen-induced TNF-dependent inflammatory oral bone loss. J Immunol (2012) 1.18
Operative laparoscopy in pregnancy. JSLS (2004) 1.17
Abdominal cerclage for the treatment of recurrent cervical insufficiency: laparoscopy or laparotomy? Am J Obstet Gynecol (2009) 1.16
Identification of immunologic and pathologic parameters of death versus survival in respiratory tularemia. Infect Immun (2007) 1.15
Chlamydia antibodies, chlamydia heat shock protein, and adverse sequelae after pelvic inflammatory disease: the PID Evaluation and Clinical Health (PEACH) Study. Sex Transm Dis (2008) 1.13
Binding of vitronectin by the Moraxella catarrhalis UspA2 protein interferes with late stages of the complement cascade. Infect Immun (2006) 1.10
Sensitization of human aortic endothelial cells to lipopolysaccharide via regulation of Toll-like receptor 4 by bacterial fimbria-dependent invasion. Infect Immun (2005) 1.10
Porphyromonas gingivalis mediated periodontal disease and atherosclerosis: disparate diseases with commonalities in pathogenesis through TLRs. Curr Pharm Des (2007) 1.09
Douching, pelvic inflammatory disease, and incident gonococcal and chlamydial genital infection in a cohort of high-risk women. Am J Epidemiol (2005) 1.09
Endometritis does not predict reproductive morbidity after pelvic inflammatory disease. Am J Obstet Gynecol (2003) 1.09
Porphyromonas gingivalis fimbria-dependent activation of inflammatory genes in human aortic endothelial cells. Infect Immun (2005) 1.08
Relative contributions of dectin-1 and complement to immune responses to particulate β-glucans. J Immunol (2012) 1.07
An evaluation of the role of properdin in alternative pathway activation on Neisseria meningitidis and Neisseria gonorrhoeae. J Immunol (2010) 1.07
Enhanced bacteremia in human factor H transgenic rats infected by Neisseria meningitidis. Infect Immun (2011) 1.06
Phosphoethanolamine residues on the lipid A moiety of Neisseria gonorrhoeae lipooligosaccharide modulate binding of complement inhibitors and resistance to complement killing. Infect Immun (2012) 1.05
A concise radiosynthesis of the tau radiopharmaceutical, [(18) F]T807. J Labelled Comp Radiopharm (2013) 1.03
Defining targets for complement components C4b and C3b on the pathogenic neisseriae. Infect Immun (2007) 1.03
Microbial carriage state of peripheral blood dendritic cells (DCs) in chronic periodontitis influences DC differentiation, atherogenic potential. J Immunol (2012) 1.02
Interleukin 1 receptor 1 and interleukin 1β regulate megakaryocyte maturation, platelet activation, and transcript profile during inflammation in mice and humans. Arterioscler Thromb Vasc Biol (2014) 1.02
Variability of bacterial vaginosis over 6- to 12-month intervals. Sex Transm Dis (2006) 1.02
Protective role for TLR4 signaling in atherosclerosis progression as revealed by infection with a common oral pathogen. J Immunol (2012) 1.02
Porphyromonas gingivalis accelerates inflammatory atherosclerosis in the innominate artery of ApoE deficient mice. Atherosclerosis (2010) 1.02
Mice lacking inducible nitric oxide synthase demonstrate impaired killing of Porphyromonas gingivalis. Infect Immun (2003) 1.01
cis- and trans-acting elements involved in regulation of norB (norZ), the gene encoding nitric oxide reductase in Neisseria gonorrhoeae. Microbiology (2008) 1.01
Depressive symptoms and sexual risk behavior in young, chlamydia-infected, heterosexual dyads. J Adolesc Health (2009) 1.00
Linkage specificity and role of properdin in activation of the alternative complement pathway by fungal glycans. MBio (2011) 0.99
Toll-like receptor 2-mediated human B cell differentiation. Clin Immunol (2006) 0.99
Novel blocking human IgG directed against the pentapeptide repeat motifs of Neisseria meningitidis Lip/H.8 and Laz lipoproteins. J Immunol (2011) 0.99
Laparoscopic abdominal cerclage. JSLS (2005) 0.97
The C-terminal domains of the gingipain K polyprotein are necessary for assembly of the active enzyme and expression of associated activities. Mol Microbiol (2004) 0.96
Polymerase chain reaction to diagnose infective endocarditis: will it replace blood cultures? Circulation (2005) 0.95
Heptose I glycan substitutions on Neisseria gonorrhoeae lipooligosaccharide influence C4b-binding protein binding and serum resistance. Infect Immun (2007) 0.94
Methicillin-resistant Staphylococcus aureus as a common cause of vulvar abscesses. Obstet Gynecol (2008) 0.94
Induction of cell signaling events by the cholera toxin B subunit in antigen-presenting cells. Infect Immun (2007) 0.93
Group A streptococcal infections in obstetrics and gynecology. Clin Obstet Gynecol (2012) 0.93
Expression of the iron-activated nspA and secY genes in Neisseria meningitidis group B by Fur-dependent and -independent mechanisms. J Bacteriol (2006) 0.92
Improved purification of native meningococcal porin PorB and studies on its structure/function. Protein Expr Purif (2005) 0.92
Human airway epithelial cell responses to Neisseria lactamica and purified porin via Toll-like receptor 2-dependent signaling. Infect Immun (2010) 0.92
Condom use and the risk of recurrent pelvic inflammatory disease, chronic pelvic pain, or infertility following an episode of pelvic inflammatory disease. Am J Public Health (2004) 0.91
The PorB porin from commensal Neisseria lactamica induces Th1 and Th2 immune responses to ovalbumin in mice and is a potential immune adjuvant. Vaccine (2007) 0.91
Properdin is critical for antibody-dependent bactericidal activity against Neisseria gonorrhoeae that recruit C4b-binding protein. J Immunol (2012) 0.91
Immunization with Porphyromonas gingivalis capsular polysaccharide prevents P. gingivalis-elicited oral bone loss in a murine model. Infect Immun (2003) 0.90
Expression of the gonococcal global regulatory protein Fur and genes encompassing the Fur and iron regulon during in vitro and in vivo infection in women. J Bacteriol (2008) 0.90
Neisseria meningitidis PorB, a TLR2 ligand, induces an antigen-specific eosinophil recall response: potential adjuvant for helminth vaccines? J Immunol (2007) 0.89
Neisseria meningitidis PorB, a Toll-like receptor 2 ligand, improves the capacity of Francisella tularensis lipopolysaccharide to protect mice against experimental tularemia. Clin Vaccine Immunol (2008) 0.89
Preterm premature rupture of the membranes is associated with a reduction in neonatal respiratory distress syndrome. Am J Obstet Gynecol (2002) 0.87
Role of protein tyrosine kinase and Erk1/2 activities in the Toll-like receptor 2-induced cellular activation of murine B cells by neisserial porin. Clin Vaccine Immunol (2008) 0.87
Immunization against a saccharide epitope accelerates clearance of experimental gonococcal infection. PLoS Pathog (2013) 0.87
Toll-like receptor 2 induces mucosal homing receptor expression and IgA production by human B cells. Clin Immunol (2010) 0.87
Characterization of a peptide vaccine candidate mimicking an oligosaccharide epitope of Neisseria gonorrhoeae and resultant immune responses and function. Vaccine (2005) 0.87
Bronchus-associated lymphoid tissue (BALT) and survival in a vaccine mouse model of tularemia. PLoS One (2010) 0.86
Regulation of the mannan-binding lectin pathway of complement on Neisseria gonorrhoeae by C1-inhibitor and alpha 2-macroglobulin. J Immunol (2002) 0.86